Bioanalytical Testing Services Market Size, Top Players, and Forecast by 2030
Bioanalytical Testing Services Market: Strategic Insights
Bioanalytical Testing Services Market
-
CAGR (2022 - 2030)10.2% -
Market Size 2022
US$ 4.64 Billion -
Market Size 2030
US$ 10.11 Billion
Market Dynamics
GROWTH DRIVERS
- Increasing Outsourcing of R&D Activities by Pharmaceutical Companies
- High Demand for Analytical Testing of Biosimilars and Biologics
FUTURE TRENDS
- Rising Drug Discovery and Development Activities for Emerging and Rare Diseases
OPPORTUNITIES
- Uninterrupted Growth of Pharmaceuticals Industry
Key Players
- SGS SA
- Pharmaron Beijing Co Ltd
- Element Materials Technology Group Ltd
- CD BioSciences Inc
- Charles River Laboratories International Inc
- Eurofins Scientific SE
- Labcorp Drug Development Inc
- Syneos Health Inc
- KCAS Bioanalytical and Biomarker Services LLC
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Services
- Pharmacokinetics
- Biomarkers
- Immunogenicity
- Virology Testing
- Cell-based assays
Disease Indication
- Cardiovascular
- Neurological Disorders
- Metabolic Disorders
- Autoimmune Disorders
- Respiratory Diseases
- Oncology
- Sexual Health
- Bone Disease
End User
- Pharmaceutical and Biopharmaceutical Companies
- Contract Research Organization
- Contract Development And Manufacturing Organization